Search results

Found 48 pages
AUTHOR: Michael Day

4 Feb 2009:

Debate as industry, academia and patient relations hit depths

Leading pharmaceutical industry figures have defended attempts by drugmakers to forge links with healthworkers and consumers, in an online debate in the British Medical Journal. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/debate_as_industry,_academia_and_patient_relations_hit_depths_985540

30 Apr 2008:

Myriad's Alzheimer treatment Flurizan causes a stir

Myriad Genetics' Flurizan (taren_urbil), the first in a new class of Alzheimer's treatments, has almost halved the rates at which symptoms progressed in a Phase II study of patients with mild forms of the dementia. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/myriads_alzheimer_treatment_flurizan_causes_a_stir_987163

8 Apr 2008:

Patient safety indicidents cost Medicare $8.8 billion

Patients safety incidents cost the US federal Medicare program $8.8 billion and - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/patient_safety_indicidents_cost_medicare_$8.8_billion_987331

25 Jan 2008:

Pill lowers women's overall cancer risk

The contraceptive pill lowers women's overall risk of cancer, experts say following a major new study in this week's issue of The Lancet. Most noticeably the Pill cuts the risk of ovarian cancer – and has so far prevented 100,000 deaths worldwide

by Michael Day

https://www.pharmatimes.com/news/pill_lowers_womens_overall_cancer_risk_985907

31 Jan 2008:

AZ teams up with top centre for cancer pain

AstraZeneca is teaming up with one of the world's top cancer treatment centres to develop new breakthroughs against cancer pain. The company said it would work with the University of Texas M D Anderson Cancer Center to advance understanding of

by Michael Day

https://www.pharmatimes.com/news/az_teams_up_with_top_centre_for_cancer_pain_985857

25 Sep 2008:

Paxil could make men infertile, researchers suggest

US scientists have claimed that one of the most commonly used selective serotonin re-uptake inhibitors, GlaxoSmithKline's Seroxat/Paxil, causes serious DNA damage in sperm cells, according to the report in New Scientist. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/paxil_could_make_men_infertile,_researchers_suggest_986739

7 Feb 2008:

Pharma marketing eyeing up nurses, report finds

The pharmaceutical industry is increasingly using its marketing operation to influence nurse-prescribers, and is being aided and abetted in this by the nursing press, it is claimed this week. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/pharma_marketing_eyeing_up_nurses,_report_finds_987739

14 Feb 2008:

Success in Asia for crackdown on counterfeit malaria pills

Experts working with Interpol and the Chinese authorities have struck a major blow against south-east Asia's life-threatening trade in fake malaria tablets. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/success_in_asia_for_crackdown_on_counterfeit_malaria_pills_987687

3 Sep 2007:

Lilly study highlights a third generation of antipsychotics

Eli Lilly researchers believe they have discovered a new class of schizophrenia medication that avoids key adverse effects seen in current treatments, not least the firm’s own blockbuster Zyprexa. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/lilly_study_highlights_a_third_generation_of_antipsychotics_990769

27 Jun 2008:

Drug licences for cash scandal unfolds in Italy

The director of Italy's medicines regulatory agency has been suspended along with another top official, as the drug licences-for-cash scandal surrounding the organisation continues to unfold. - News - PharmaTimes

by Michael Day

https://www.pharmatimes.com/news/drug_licences_for_cash_scandal_unfolds_in_italy_988413